Im­mune Reg­u­la­tion, tak­ing two clin­i­cal pro­grams to 're­set' the im­mune sys­tem, nets $53M+ Se­ries B

A lit­tle un­der two years af­ter a com­pa­ny re­brand­ing, Im­mune Reg­u­la­tion is tak­ing an even big­ger step to­ward ad­vanc­ing its goals.

For­mer­ly known as Peptin­no­vate …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER